Gregory S Patrick - Net Worth and Insider Trading

Gregory S Patrick Net Worth

The estimated net worth of Gregory S Patrick is at least $1 Million dollars as of 2024-04-27. Gregory S Patrick is the Sr. VP CFO of Supernus Pharmaceuticals Inc and owns about 44,463 shares of Supernus Pharmaceuticals Inc (SUPN) stock worth over $1 Million. Details can be seen in Gregory S Patrick's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gregory S Patrick has not made any transactions after 2020-11-09 and currently still holds the listed stock(s).

Transaction Summary of Gregory S Patrick

To

Gregory S Patrick Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gregory S Patrick owns 1 companies in total, including Supernus Pharmaceuticals Inc (SUPN) .

Click here to see the complete history of Gregory S Patrick’s form 4 insider trades.

Insider Ownership Summary of Gregory S Patrick

Ticker Comapny Transaction Date Type of Owner
SUPN Supernus Pharmaceuticals Inc 2020-11-09 VP & Chief Financial Officer

Gregory S Patrick Latest Holdings Summary

Gregory S Patrick currently owns a total of 1 stock. Gregory S Patrick owns 44,463 shares of Supernus Pharmaceuticals Inc (SUPN) as of November 9, 2020, with a value of $1 Million.

Latest Holdings of Gregory S Patrick

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SUPN Supernus Pharmaceuticals Inc 2020-11-09 44,463 30.07 1,337,002

Holding Weightings of Gregory S Patrick


Gregory S Patrick Form 4 Trading Tracker

According to the SEC Form 4 filings, Gregory S Patrick has made a total of 5 transactions in Supernus Pharmaceuticals Inc (SUPN) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Supernus Pharmaceuticals Inc is the sale of 5,000 shares on November 9, 2020, which brought Gregory S Patrick around $125,000.

Insider Trading History of Gregory S Patrick

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gregory S Patrick Trading Performance

GuruFocus tracks the stock performance after each of Gregory S Patrick's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gregory S Patrick is 44.64%. GuruFocus also compares Gregory S Patrick's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gregory S Patrick within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gregory S Patrick's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gregory S Patrick

Average Return

16.1%

Average return per transaction

Outperforming Transactions

50%

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -19.36 44.64 44.71 16.1 23.23 30.69
Relative Return to S&P 500(%) -16.86 41.81 39.07 -1.75 7.28 18.44

Gregory S Patrick Ownership Network

Ownership Network List of Gregory S Patrick

No Data

Ownership Network Relation of Gregory S Patrick


Gregory S Patrick Owned Company Details

What does Supernus Pharmaceuticals Inc do?

Who are the key executives at Supernus Pharmaceuticals Inc?

Gregory S Patrick is the VP & Chief Financial Officer of Supernus Pharmaceuticals Inc. Other key executives at Supernus Pharmaceuticals Inc include Sr. VP of IP & CSO Padmanabh P. Bhatt , Sr. V.P. & Regulatory Affairs Tami Tillotson Martin , and Sr VP & Quality & GMP Oper. & IT Frank Mottola .

Supernus Pharmaceuticals Inc (SUPN) Insider Trades Summary

Over the past 18 months, Gregory S Patrick made no insider transaction in Supernus Pharmaceuticals Inc (SUPN). Other recent insider transactions involving Supernus Pharmaceuticals Inc (SUPN) include a net sale of 116,005 shares made by Padmanabh P. Bhatt , a net sale of 76,390 shares made by Jack A. Khattar , and a net sale of 21,235 shares made by Tami Tillotson Martin .

In summary, during the past 3 months, insiders sold 98,505 shares of Supernus Pharmaceuticals Inc (SUPN) in total and bought 0 shares, with a net sale of 98,505 shares. During the past 18 months, 231,113 shares of Supernus Pharmaceuticals Inc (SUPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 231,113 shares.

Supernus Pharmaceuticals Inc (SUPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Supernus Pharmaceuticals Inc Insider Transactions

No Available Data

Gregory S Patrick Mailing Address

Above is the net worth, insider trading, and ownership report for Gregory S Patrick. You might contact Gregory S Patrick via mailing address: C/o Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville Md 20850.

Discussions on Gregory S Patrick

No discussions yet.